Skip to Content
Merck
  • Macro/Nano-gel composite as an injectable and bioactive bulking material for the treatment of urinary incontinence.

Macro/Nano-gel composite as an injectable and bioactive bulking material for the treatment of urinary incontinence.

Biomacromolecules (2014-04-18)
Kyung Min Park, Joo Young Son, Jong Hoon Choi, In Gul Kim, Yunki Lee, Ji Youl Lee, Ki Dong Park
ABSTRACT

Many women around the world are suffering from urinary incontinence, defined as the unintentional leakage of urine by external abnormal pressure. Although various kinds of materials have been utilized to treat this disease, therapies that are more effective are still needed for the treatment of urinary incontinence. Here, we present a macro/nanogel composed of in situ forming gelatin-based macrogels and self-assembled heparin-based nanogels, which can serve as an injectable and bioactive bulking material for the treatment of urinary incontinence. The hybrid hydrogels were prepared via enzymatic reaction in the presence of horseradish peroxidase and hydrogen peroxide. Incorporating a growth factor (GF)-loaded heparin nanogel into a gelatin gel matrix enabled the hybrid gel matrix to release GF continuously up to 28 days. Moreover, we demonstrated that the hydrogel composites stimulated the regeneration of the urethral muscle tissue surrounding the urethral wall and promoted the recovery of their biological function when injected in vivo. Thus, the macro/nanohydrogels may provide an advanced therapeutic technique for the treatment of urinary incontinence as well as an application for regenerative medicine.

MATERIALS
Product Number
Brand
Product Description

Valaciclovir impurity G, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Dimethyl sulfoxide, Hybri-Max, sterile-filtered, BioReagent, suitable for hybridoma, ≥99.7%
Sigma-Aldrich
Dimethyl sulfoxide, ≥99.5% (GC), suitable for plant cell culture
Sigma-Aldrich
Dimethyl sulfoxide, PCR Reagent
Sigma-Aldrich
Dimethyl sulfoxide, for molecular biology
Sigma-Aldrich
4-(Dimethylamino)pyridine, purum, ≥98.0% (NT)
USP
Valacyclovir Related Compound G, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Dimethyl sulfoxide, sterile-filtered, BioPerformance Certified, meets EP, USP testing specifications, suitable for hybridoma
Sigma-Aldrich
Dimethyl sulfoxide, meets EP testing specifications, meets USP testing specifications
Sigma-Aldrich
Dimethyl sulfoxide, BioUltra, for molecular biology, ≥99.5% (GC)
Sigma-Aldrich
8-Octanoyloxypyrene-1,3,6-trisulfonic acid trisodium salt, suitable for fluorescence, ≥90% (HPCE)
Sigma-Aldrich
4-(Dimethylamino)pyridine, ReagentPlus®, ≥99%
Supelco
Dimethyl sulfoxide, analytical standard
Sigma-Aldrich
Succinic anhydride, ≥99% (GC)
Sigma-Aldrich
Tyramine, ≥98.0%
Sigma-Aldrich
Dimethyl sulfoxide, ReagentPlus®, ≥99.5%
Dimethyl sulfoxide, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Dimethyl sulfoxide, suitable for HPLC, ≥99.7%
Sigma-Aldrich
Dimethyl sulfoxide, ACS reagent, ≥99.9%
Supelco
Dimethyl sulfoxide, for inorganic trace analysis, ≥99.99995% (metals basis)
Sigma-Aldrich
Tyramine, 98%, FG
Sigma-Aldrich
Human bFGF ELISA Kit, for cell and tissue lysates
Sigma-Aldrich
Mouse bFGF ELISA Kit, for serum, plasma and cell culture supernatant
Sigma-Aldrich
Human bFGF ELISA Kit, for serum, plasma, cell culture supernatant and urine
USP
Dimethyl sulfoxide, United States Pharmacopeia (USP) Reference Standard
Supelco
Tyramine, analytical standard